Roche stock jumps on positive obesity drug trial results
In this article:
Shares of Roche (ROG.SW) are moving higher on Wednesday as the company announced positive results from its obesity drug trial, a once-a-day oral pill, currently labeled CT-996. The results are putting pressure on obesity drug makers Novo Nordisk (NVO) and Eli Lilly (LLY)
Yahoo Finance Reporter Anjalee Khemlani joins Morning Brief to break down the latest development for Roche and what it means for the company moving forward.
For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.
This post was written by Nicholas Jacobino